Trial Profile
Comparison of Zolpidem Tartrate Extended-Release vs. Placebo in Treatment of Insomnia Associated With Newly Diagnosed Major Depressive Disorder (MDD) or Untreated MDD Relapse, When Used Concomitantly With Escitalopram
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Zolpidem (Primary) ; Escitalopram
- Indications Insomnia; Major depressive disorder
- Focus Therapeutic Use
- Sponsors Sanofi
- 10 Jun 2008 Results presented at APSS 2008, according to a sanofi-aventis media release.
- 05 Sep 2007 Status changed from in progress to completed.
- 17 Jan 2007 Status change